Director, New Products Strategy Innovation

Ipsen•Cambridge, MA

16h

About The Position

Ipsen is a mid-sized global biopharmaceutical company with a focus on transformative medicines in three therapeutic areas: Oncology, Rare Disease and Neuroscience. Supported by nearly 100 years of development experience, with global hubs in the U.S., France and the U.K, we tackle areas of high unmet medical need through research and innovation. Our passionate teams in more than 40 countries are focused on what matters and endeavor every day to bring medicines to patients in 88 countries. We build a workplace that champions human-centric leadership and fosters a culture of collaboration, excellence and impact. At Ipsen, every individual is empowered to be their true selves, grow and thrive alongside the company’s success. Join us on our journey towards sustainable growth, creating real impact on patients and society! For more information, visit us at https://www.ipsen.com/ and follow our latest news on LinkedIn and Instagram. To support New Products & Franchise Leadership in Oncology, Rare Diseases and Neurosciences across: Therapeutic Area & Franchise Strategy Evolution Commercial evaluations of new global business opportunities Business Development / External Innovation Internal Pipeline Commercial Planning At Ipsen, our vision is to be a leading global mid-size biopharmaceutical company, with a focus on transformative medicines in three key therapeutic areas: oncology, rare disease, and neuroscience. A key strategic focus for us in meeting this objective is business development & partnering. In the last three years, we brought in over 20 new assets into our portfolio across various stages of development and across our three key therapeutic areas through licensing, partnering and collaborations. In 2025 and beyond, we plan to continue our strategic focus and execution in creating a balanced & sustainable pipeline across therapeutic areas. As such we are looking to expand our New Products team to lead the commercial evaluations of external opportunities and support planning around our internal pipeline with overall goal to meet our strategic objectives & vision as business. Provide a brief overview of the position's purpose, its role within the organization, and impact at Ipsen.

Requirements

Significant experience in early commercial or BD roles within a pharmaceutical or biopharmaceutical industry at global level, or Strategy Consulting experience in life sciences (including work in early-commercial strategy, commercialization, LCM, BD, due diligence, etc.)
Experience in early commercial planning, launch planning and disease area strategy either as part of a pharmaceutical/ biopharma or a consultancy company
Experience in working across a cross-functional matrix team to meet deliverables on time and budget
Strong scientific, medical, and commercial experience in oncology and rare diseases with a proven knowledge of business development and launch activities
Strong communication and presentation skills
Demonstrated exceptional strategic thinking
Sense of urgency and experience in delivering parallel workstreams efficiently
Deep strategic marketing expertise (diseases areas in oncology, rare, disease & neuroscience, positioning, targeting, segmentation, life cycle management)
Strong business acumen and understanding of global markets
Excellent analytical skills and strategic thinking
Competitive landscaping
Conducting qualitative & quantitative market research
Strong planning and project management skills
Excellent business case modelling and presentation skills (Excel & PowerPoint use)
Advanced degree (PhD, MD, or MS) in Life Sciences-related discipline and/or an MBA
Fluency in spoken and written English

Nice To Haves

Knowledge of additional languages such as French would be helpful.

Responsibilities

Support New Products Head and work collaboratively with cross-functional team leading strategy process (e.g., business development, external innovation, franchise, R&D, strategy & transformation)
Conduct analysis across key areas to support the continuous evolution and update of the therapeutic area strategy (e.g., landscaping assessments, benchmarking, analogue analysis etc.) and develop story / slide generation of strategic outputs as they evolve.
Work with internal Asset Teams as appropriate to capture relevant insights to support external innovation strategy.
Be the commercial lead across all stages of the business development & external innovation process: screening, triage/deep-dive and due diligence
Work in collaboration with external innovation teams in sourcing new assets across oncology and rare diseases based on our strategy
Lead the commercial triage of new business development opportunities, including disease assessment, competitive landscaping, market sizing and risk & opportunity assessment
Representing Franchise on company calls with potential partners
Lead the commercial evaluation of assets in due diligence
Conduct in-depth commercial evaluation and be the lead content generator (e.g., current & future landscaping, secondary and primary market research, forecasting, pricing & access assessment, SMM estimation, etc.)
Be a proactive partner and work collaboratively with cross-functional teams (e.g., business development, external innovation, medical affairs, R&D, regulatory, finance, countries, global pricing & access, business excellence) to support inputs required for commercial modelling launch dates, LOE, duration of treatment, LCM indications etc.
Ensure streamlined, efficient, and quality content generation across all evaluations aligning with internal processes
Synthesize findings & present recommendations to cross-functional team and leadership teams
Lead early commercial planning process for internal pipeline products across oncology and rare diseases. E.g., Indication prioritization, portfolio strategy, LCM planning, business case development
Facilitate analysis required to support commercialization and/or continued development for new products
Support the cross-functional team & local country teams in pre-launch activities, playing a pivotal role in the transition of these activities to a fully dedicated Global Brand Team as the asset moves through the lifecycle. E.g. Key deliverables: Brand strategy & launch plan, launch readiness review, campaign & core messaging, global launch sequence, LCM indications prioritization etc.
Work collaboratively with R&D and other critical functions within the Global Asset Team to ensure efficient execution with a long-term commercial vision.